Literature DB >> 26032267

Cancer immunotherapy: exploiting neoepitopes.

Michael Platten1, Rienk Offringa2.   

Abstract

The efficacy of cancer vaccines has long been hampered by insufficient definition of tumor-specific antigens. A recent study by Kreiter et al. published in Nature has provided a blueprint for a patient-tailored approach to develop individualized RNA vaccines.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26032267      PMCID： PMC4528051          DOI： 10.1038/cr.2015.66

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  12 in total

1.  Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Authors:  Sebastian Kreiter; Mathias Vormehr; Niels van de Roemer; Mustafa Diken; Martin Löwer; Jan Diekmann; Sebastian Boegel; Barbara Schrörs; Fulvia Vascotto; John C Castle; Arbel D Tadmor; Stephen P Schoenberger; Christoph Huber; Özlem Türeci; Ugur Sahin
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

2.  Genetic basis for clinical response to CTLA-4 blockade in melanoma.

Authors:  Alexandra Snyder; Vladimir Makarov; Taha Merghoub; Jianda Yuan; Jedd D Wolchok; Timothy A Chan; Jesse M Zaretsky; Alexis Desrichard; Logan A Walsh; Michael A Postow; Phillip Wong; Teresa S Ho; Travis J Hollmann; Cameron Bruggeman; Kasthuri Kannan; Yanyun Li; Ceyhan Elipenahli; Cailian Liu; Christopher T Harbison; Lisu Wang; Antoni Ribas
Journal:  N Engl J Med       Date:  2014-11-19       Impact factor: 91.245

3.  A vaccine targeting mutant IDH1 induces antitumour immunity.

Authors:  Theresa Schumacher; Lukas Bunse; Stefan Pusch; Felix Sahm; Benedikt Wiestler; Jasmin Quandt; Oliver Menn; Matthias Osswald; Iris Oezen; Martina Ott; Melanie Keil; Jörg Balß; Katharina Rauschenbach; Agnieszka K Grabowska; Isabel Vogler; Jan Diekmann; Nico Trautwein; Stefan B Eichmüller; Jürgen Okun; Stefan Stevanović; Angelika B Riemer; Ugur Sahin; Manuel A Friese; Philipp Beckhove; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

4.  Proximity ligation assay evaluates IDH1R132H presentation in gliomas.

Authors:  Lukas Bunse; Theresa Schumacher; Felix Sahm; Stefan Pusch; Iris Oezen; Katharina Rauschenbach; Marina Gonzalez; Gergely Solecki; Matthias Osswald; David Capper; Benedikt Wiestler; Frank Winkler; Christel Herold-Mende; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

5.  Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.

Authors:  Sergio A Quezada; Tyler R Simpson; Karl S Peggs; Taha Merghoub; Jelena Vider; Xiaozhou Fan; Ronald Blasberg; Hideo Yagita; Pawel Muranski; Paul A Antony; Nicholas P Restifo; James P Allison
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

6.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

7.  T-helper-1-cell cytokines drive cancer into senescence.

Authors:  Heidi Braumüller; Thomas Wieder; Ellen Brenner; Sonja Aßmann; Matthias Hahn; Mohammed Alkhaled; Karin Schilbach; Frank Essmann; Manfred Kneilling; Christoph Griessinger; Felicia Ranta; Susanne Ullrich; Ralph Mocikat; Kilian Braungart; Tarun Mehra; Birgit Fehrenbacher; Julia Berdel; Heike Niessner; Friedegund Meier; Maries van den Broek; Hans-Ulrich Häring; Rupert Handgretinger; Leticia Quintanilla-Martinez; Falko Fend; Marina Pesic; Jürgen Bauer; Lars Zender; Martin Schaller; Klaus Schulze-Osthoff; Martin Röcken
Journal:  Nature       Date:  2013-02-03       Impact factor: 49.962

Review 8.  Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see).

Authors:  Ludger Klein; Bruno Kyewski; Paul M Allen; Kristin A Hogquist
Journal:  Nat Rev Immunol       Date:  2014-05-16       Impact factor: 53.106

9.  Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Authors:  Matthew M Gubin; Xiuli Zhang; Heiko Schuster; Etienne Caron; Jeffrey P Ward; Takuro Noguchi; Yulia Ivanova; Jasreet Hundal; Cora D Arthur; Willem-Jan Krebber; Gwenn E Mulder; Mireille Toebes; Matthew D Vesely; Samuel S K Lam; Alan J Korman; James P Allison; Gordon J Freeman; Arlene H Sharpe; Erika L Pearce; Ton N Schumacher; Ruedi Aebersold; Hans-Georg Rammensee; Cornelis J M Melief; Elaine R Mardis; William E Gillanders; Maxim N Artyomov; Robert D Schreiber
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

10.  Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.

Authors:  Paul F Robbins; Yong-Chen Lu; Mona El-Gamil; Yong F Li; Colin Gross; Jared Gartner; Jimmy C Lin; Jamie K Teer; Paul Cliften; Eric Tycksen; Yardena Samuels; Steven A Rosenberg
Journal:  Nat Med       Date:  2013-05-05       Impact factor: 53.440
View more
  6 in total

Review 1.  Advances in immunotherapeutic research for glioma therapy.

Authors:  Jeremy Tetsuo Miyauchi; Stella E Tsirka
Journal:  J Neurol       Date:  2017-12-05       Impact factor: 4.849

Review 2.  Vaccine Strategies in Gliomas.

Authors:  Michael Platten; Lukas Bunse; Dennis Riehl; Theresa Bunse; Katharina Ochs; Wolfgang Wick
Journal:  Curr Treat Options Neurol       Date:  2018-03-28       Impact factor: 3.598

Review 3.  Vaccine-based immunotherapeutic approaches to gliomas and beyond.

Authors:  Michael Weller; Patrick Roth; Matthias Preusser; Wolfgang Wick; David A Reardon; Michael Platten; John H Sampson
Journal:  Nat Rev Neurol       Date:  2017-05-12       Impact factor: 42.937

4.  A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.

Authors:  Jugmohit S Toor; Arjun A Rao; Andrew C McShan; Mark Yarmarkovich; Santrupti Nerli; Karissa Yamaguchi; Ada A Madejska; Son Nguyen; Sarvind Tripathi; John M Maris; Sofie R Salama; David Haussler; Nikolaos G Sgourakis
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

5.  First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine.

Authors:  Luis Martínez; Carmen Alvarez-Dominguez; Iker Malaina; David Salcines-Cuevas; Héctor Terán-Navarro; Andrea Zeoli; Santos Alonso; Ildefonso M De la Fuente; Elena Gonzalez-Lopez; J Gonzalo Ocejo-Vinyals; Mónica Gozalo-Margüello; Jorge Calvo-Montes
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

6.  Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers.

Authors:  Shahida Din; Kim Wong; Mike F Mueller; Anca Oniscu; James Hewinson; Catherine J Black; Martin L Miller; Alejandro Jiménez-Sánchez; Roy Rabbie; Mamunar Rashid; Jack Satsangi; David J Adams; Mark J Arends
Journal:  Clin Cancer Res       Date:  2018-06-27       Impact factor: 12.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.